BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7528264)

  • 1. Characterization of the substance P (NK-1) receptor in tunicamycin-treated transfected cells using a photoaffinity analogue of substance P.
    Kage R; Hershey AD; Krause JE; Boyd ND; Leeman SE
    J Neurochem; 1995 Jan; 64(1):316-21. PubMed ID: 7528264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
    Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
    J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
    Bremer AA; Leeman SE; Boyd ND
    FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of methionine as the site of covalent attachment of a p-benzoyl-phenylalanine-containing analogue of substance P on the substance P (NK-1) receptor.
    Kage R; Leeman SE; Krause JE; Costello CE; Boyd ND
    J Biol Chem; 1996 Oct; 271(42):25797-800. PubMed ID: 8824208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
    Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
    Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.
    Bremer AA; Leeman SE; Boyd ND
    J Biol Chem; 2001 Jun; 276(25):22857-61. PubMed ID: 11294866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the peptide binding domain of the NK-1 tachykinin receptor using photoreactive analogues of substance P.
    Boyd ND; Kage R; Dumas JJ; Silberman SC; Krause JE; Leeman SE
    Ann N Y Acad Sci; 1995 May; 757():405-9. PubMed ID: 7541973
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological properties of FK886, a new, centrally active neurokinin-1 receptor antagonist.
    Yoshino-Furukawa T; Maeda Y; Kikuchi A; Sakuma H; Imazumi K; Yamakuni H; Sogabe H; Matsuo M; Manda T; Uchida W
    Biol Pharm Bull; 2013; 36(1):76-81. PubMed ID: 23302639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent molecular weight of substance P/neurokinin-1 receptors determined using a photoaffinity labelled probe, [(3'-125I) D-Tyro, (4'-N3)Phe8, Nle11]-substance P.
    Dam TV; Escher E; Quirion R
    Biochem Biophys Res Commun; 1987 Nov; 149(1):297-303. PubMed ID: 2446621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further definition of the substance P (SP)/neurokinin-1 receptor complex. MET-174 is the site of photoinsertion p-benzoylphenylalanine4 SP.
    Li H; Macdonald DM; Hronowski X; Costello CE; Leeman SE; Boyd ND
    J Biol Chem; 2001 Apr; 276(14):10589-93. PubMed ID: 11116140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling the substance P receptor using a derivative of substance P containing p-benzoylphenylalanine.
    Boyd ND; White CF; Cerpa R; Kaiser ET; Leeman SE
    Biochemistry; 1991 Jan; 30(2):336-42. PubMed ID: 1703017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
    Ciucci A; Palma C; Manzini S; Werge TM
    Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis.
    Hastrup H; Schwartz TW
    FEBS Lett; 1996 Dec; 399(3):264-6. PubMed ID: 8985159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of mucin secretion from CHO-K1-hNK(1)R cells.
    Caccese R; Graham A; Bialecki R
    Neuropeptides; 1999 Jun; 33(3):239-43. PubMed ID: 10657498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
    Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.
    Sagan S; Beaujouan JC; Torrens Y; Saffroy M; Chassaing G; Glowinski J; Lavielle S
    Mol Pharmacol; 1997 Jul; 52(1):120-7. PubMed ID: 9224821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
    Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
    Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar rates of phosphatidylinositol hydrolysis following activation of wild-type and truncated rat neurokinin-1 receptors.
    Raddatz R; Crankshaw CL; Snider RM; Krause JE
    J Neurochem; 1995 Mar; 64(3):1183-91. PubMed ID: 7532207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cells.
    Hermans E; Jeanjean AP; Fardin V; Pradier L; Garret C; Laduron PM; Octave JN; Maloteaux JM
    Eur J Pharmacol; 1993 Mar; 245(1):43-50. PubMed ID: 7682962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist.
    Cascieri MA; Ber E; Fong TM; Hale JJ; Tang F; Shiao LL; Mills SG; MacCoss M; Sadowski S; Tota MR; Strader CD
    Eur J Pharmacol; 1997 May; 325(2-3):253-61. PubMed ID: 9163573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.